Cargando…
Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury
INTRODUCTION: Studies have shown that stem cells exert their therapeutic effects on acute kidney injury (AKI) through paracrine/endocrine actions. If the protective effect is mediated in an endocrine manner, the injection of the factors that these cells secrete could be effective, but the effect of...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159523/ https://www.ncbi.nlm.nih.gov/pubmed/25145540 http://dx.doi.org/10.1186/scrt489 |
_version_ | 1782334236842262528 |
---|---|
author | Xing, Li Cui, Rui Peng, Lei Ma, Jing Chen, Xiao Xie, Ru-Juan Li, Bing |
author_facet | Xing, Li Cui, Rui Peng, Lei Ma, Jing Chen, Xiao Xie, Ru-Juan Li, Bing |
author_sort | Xing, Li |
collection | PubMed |
description | INTRODUCTION: Studies have shown that stem cells exert their therapeutic effects on acute kidney injury (AKI) through paracrine/endocrine actions. If the protective effect is mediated in an endocrine manner, the injection of the factors that these cells secrete could be effective, but the effect of conditioned medium (CM) remains controversial. METHODS: In this study, we cultured mesenchymal stem cells (MSCs) and then transplanted them into an ischemia-reperfusion (I/R) injury model. CM was also injected into mice, and the histological changes, level of cell proliferation, loss of peritubular capillaries and anti-inflammatory and anti-apoptotic effects were examined at different time points. RESULTS: The results showed that MSC infusion improved renal function and histological alterations, leading to significantly reduced mortality. MSC administration also promoted kidney microvasculature repair, attenuated kidney peritubular capillary loss, increased the proliferation of parenchymal cells and decreased CD68-positive macrophage infiltration and apoptotic cells. Although we determined that CM contained proangiogenic factors, including hepatocyte growth factor (HGF), vascular endothelial growth factor-A (VEGF-A) and insulin-like growth factor-1 (IGF-1), no favorable effects were observed during the course of repair. CONCLUSIONS: Our data show that MSC infusion promotes kidney repair in a variety of ways, including enhancement of the repair of peritubular capillaries and tubular epithelial cells and anti-inflammatory and anti-apoptotic effects. MSCs can secrete high levels of proangiogenic growth factors, but CM results in a nonsignificant improvement, indicating that MSCs play a role in kidney repair through paracrine rather than endocrine mechanisms. These results indicate that MSC infusion is a promising therapeutic strategy for promoting kidney repair after injury. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/scrt489) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4159523 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41595232014-09-11 Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury Xing, Li Cui, Rui Peng, Lei Ma, Jing Chen, Xiao Xie, Ru-Juan Li, Bing Stem Cell Res Ther Research INTRODUCTION: Studies have shown that stem cells exert their therapeutic effects on acute kidney injury (AKI) through paracrine/endocrine actions. If the protective effect is mediated in an endocrine manner, the injection of the factors that these cells secrete could be effective, but the effect of conditioned medium (CM) remains controversial. METHODS: In this study, we cultured mesenchymal stem cells (MSCs) and then transplanted them into an ischemia-reperfusion (I/R) injury model. CM was also injected into mice, and the histological changes, level of cell proliferation, loss of peritubular capillaries and anti-inflammatory and anti-apoptotic effects were examined at different time points. RESULTS: The results showed that MSC infusion improved renal function and histological alterations, leading to significantly reduced mortality. MSC administration also promoted kidney microvasculature repair, attenuated kidney peritubular capillary loss, increased the proliferation of parenchymal cells and decreased CD68-positive macrophage infiltration and apoptotic cells. Although we determined that CM contained proangiogenic factors, including hepatocyte growth factor (HGF), vascular endothelial growth factor-A (VEGF-A) and insulin-like growth factor-1 (IGF-1), no favorable effects were observed during the course of repair. CONCLUSIONS: Our data show that MSC infusion promotes kidney repair in a variety of ways, including enhancement of the repair of peritubular capillaries and tubular epithelial cells and anti-inflammatory and anti-apoptotic effects. MSCs can secrete high levels of proangiogenic growth factors, but CM results in a nonsignificant improvement, indicating that MSCs play a role in kidney repair through paracrine rather than endocrine mechanisms. These results indicate that MSC infusion is a promising therapeutic strategy for promoting kidney repair after injury. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/scrt489) contains supplementary material, which is available to authorized users. BioMed Central 2014-08-21 /pmc/articles/PMC4159523/ /pubmed/25145540 http://dx.doi.org/10.1186/scrt489 Text en © Xing et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Xing, Li Cui, Rui Peng, Lei Ma, Jing Chen, Xiao Xie, Ru-Juan Li, Bing Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury |
title | Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury |
title_full | Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury |
title_fullStr | Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury |
title_full_unstemmed | Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury |
title_short | Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury |
title_sort | mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159523/ https://www.ncbi.nlm.nih.gov/pubmed/25145540 http://dx.doi.org/10.1186/scrt489 |
work_keys_str_mv | AT xingli mesenchymalstemcellsnotconditionedmediumcontributetokidneyrepairafterischemiareperfusioninjury AT cuirui mesenchymalstemcellsnotconditionedmediumcontributetokidneyrepairafterischemiareperfusioninjury AT penglei mesenchymalstemcellsnotconditionedmediumcontributetokidneyrepairafterischemiareperfusioninjury AT majing mesenchymalstemcellsnotconditionedmediumcontributetokidneyrepairafterischemiareperfusioninjury AT chenxiao mesenchymalstemcellsnotconditionedmediumcontributetokidneyrepairafterischemiareperfusioninjury AT xierujuan mesenchymalstemcellsnotconditionedmediumcontributetokidneyrepairafterischemiareperfusioninjury AT libing mesenchymalstemcellsnotconditionedmediumcontributetokidneyrepairafterischemiareperfusioninjury |